Specifically, Joseph focuses on developing programs that will help African-American women to address their needs in breast cancer prevention and care.
[4] She is also studying the effects of a cell surface receptor molecule called RAGE which appears to play a role in tumor growth.
[4] Kathie-Ann Joseph is the first African-American woman to be appointed to the faculty at New York-Presbyterian Hospital/Columbia University Medical Center in the Department of Surgery.
[citation needed] Joseph's research includes studying a cell surface receptor molecule called RAGE which plays a role in tumor growth.
[4] In addition to RAGE, Joseph also focuses her research on risk factors associated with cancer including genetics, age, race, and ethnicity.
[14] She is also involved in testing new equipment that uses infrared rays to detect lesions,[2] and in 2017, led a study to treat benign tumors with high intensity frequency ultrasound.
[15] While attending Harvard University, Joseph was awarded the Hoopes Prize for Excellence in Undergraduate Research for her thesis called Triple Jeopardy: Elderly, Poor, African-American Women and Their Barriers to Health Care and Screening for Breast and Cervical Cancer.